Funds holding Ascendis Pharma A/S
ISIN US04351P1012 · Denmark · LEI 549300B66JN3W3J8GH73
- Fund holders
- 180
- Of which ETFs
- 21 159 other funds
- Value held
- 3.3B $ 118M SEK · 181.5K €
This issuer has other securities : Ascendis Pharma A/S (DK0060615755)
180 funds hold this company. This table lists the 179 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| MFS Mid Cap Growth Fund MFS Series Trust IV | 1,279,738 | 298.8M $ | 2.17 % | as of Feb 28, 2026 ↗ |
| Growth Fund of America Growth Fund of America | 1,209,675 | 282.5M $ | 0.09 % | as of Feb 28, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 1,100,000 | 251.6M $ | 1.02 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 716,000 | 167.2M $ | 2.70 % | as of Feb 28, 2026 ↗ |
| Artisan Mid Cap Fund Artisan Partners Funds Inc. | 678,343 | 155.2M $ | 5.25 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 603,319 | 138M $ | 1.00 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 579,165 | 132.5M $ | 0.16 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 558,201 | 130.3M $ | 2.44 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 547,381 | 125.2M $ | 1.36 % | as of Mar 31, 2026 ↗ |
| New Perspective Fund New Perspective Fund | 463,385 | 106M $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 444,896 | 101.8M $ | 0.21 % | as of Mar 31, 2026 ↗ |
| CTIVP - Westfield Select Large Cap Growth Fund Columbia Funds Variable Series Trust II | 355,189 | 81.2M $ | 5.18 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 339,948 | 77.8M $ | 0.96 % | as of Mar 31, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 334,360 | 76.5M $ | 4.24 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 333,325 | 76.2M $ | 1.23 % | as of Mar 31, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 272,292 | 62.3M $ | 0.95 % | as of Mar 31, 2026 ↗ |
| Artisan Small Cap Fund Artisan Partners Funds Inc. | 228,403 | 52.2M $ | 5.87 % | as of Mar 31, 2026 ↗ |
| Spyglass Growth Fund Manager Directed Portfolios | 216,236 | 49.5M $ | 5.90 % | as of Mar 31, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 194,855 | 44.6M $ | 0.96 % | as of Mar 31, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 175,000 | 40M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Nomura Mid Cap Growth Fund IVY FUNDS | 146,632 | 33.5M $ | 1.12 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 138,500 | 31.7M $ | 0.79 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 132,000 | 30.8M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Tax Managed Small/Mid Cap Fund Bridge Builder Trust | 126,916 | 29M $ | 0.96 % | as of Mar 31, 2026 ↗ |
| Putnam Global Health Care Fund Putnam Global Health Care Fund | 113,788 | 26.6M $ | 1.67 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 110,000 | 25.2M $ | 2.50 % | as of Mar 31, 2026 ↗ |
| Putnam Small Cap Growth Fund Putnam Funds Trust | 103,216 | 23.6M $ | 0.87 % | as of Mar 31, 2026 ↗ |
| Nomura International Core Equity Fund IVY FUNDS | 96,163 | 22M $ | 1.82 % | as of Mar 31, 2026 ↗ |
| Nomura Asset Strategy Fund IVY FUNDS | 81,446 | 18.6M $ | 1.08 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 81,267 | 19M $ | 0.91 % | as of Feb 28, 2026 ↗ |
| Mercer US Small/Mid Cap Equity Fund Mercer Funds | 75,367 | 17.2M $ | 1.01 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 71,578 | 16.4M $ | 0.59 % | as of Mar 31, 2026 ↗ |
| Columbia Select Mid Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 67,812 | 15.8M $ | 0.80 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Growth Opportunities Fund Fidelity Advisor Series I | 67,662 | 15.8M $ | 0.05 % | as of Feb 28, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 65,010 | 14.9M $ | 0.78 % | as of Mar 31, 2026 ↗ |
| Nomura Global Growth Fund IVY FUNDS | 64,079 | 14.7M $ | 1.81 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 60,527 | 13.8M $ | 0.04 % | as of Mar 31, 2026 ↗ |
| EQ/MFS Mid Cap Focused Growth Portfolio EQ Advisors Trust | 59,718 | 13.7M $ | 2.79 % | as of Mar 31, 2026 ↗ |
| JNL/Invesco Small Cap Growth Fund JNL Series Trust | 57,900 | 13.2M $ | 0.85 % | as of Mar 31, 2026 ↗ |
| Invesco Small Cap Growth Fund AIM Growth Series (Invesco Growth Series) | 57,530 | 13.2M $ | 0.85 % | as of Mar 31, 2026 ↗ |
| Invesco Small Cap Equity Fund AIM Funds Group (Invesco Funds Group) | 56,036 | 12.8M $ | 1.26 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 54,161 | 12.6M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Nomura VIP International Core Equity Series Ivy Variable Insurance Portfolios | 53,447 | 12.2M $ | 1.82 % | as of Mar 31, 2026 ↗ |
| Allspring SMID Cap Growth Fund ALLSPRING FUNDS TRUST | 51,783 | 11.8M $ | 1.47 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 50,270 | 11.5M $ | 0.70 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 48,658 | 11.1M $ | 1.23 % | as of Mar 31, 2026 ↗ |
| American Century Focused Dynamic Growth ETF American Century ETF Trust | 45,193 | 10.6M $ | 3.10 % | as of Feb 28, 2026 ↗ |
| BNY Mellon Research Growth Fund, Inc. BNY MELLON RESEARCH GROWTH FUND, INC. | 43,278 | 10.1M $ | 0.63 % | as of Feb 28, 2026 ↗ |
| BNY Mellon Small/Mid Cap Growth Fund BNY Mellon Investment Funds I | 42,147 | 9.6M $ | 1.26 % | as of Mar 31, 2026 ↗ |
| VIP Stock Selector Portfolio Variable Insurance Products Fund | 40,000 | 9.1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 38,665 | 84.2M SEK | 0.52 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 36,801 | 8.4M $ | 0.80 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 35,982 | 8.4M $ | 0.04 % | as of Feb 28, 2026 ↗ |
| Capital Appreciation Value Fund John Hancock Funds II | 35,887 | 8.4M $ | 0.77 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 35,334 | 8.3M $ | 0.67 % | as of Feb 28, 2026 ↗ |
| CTIVP - Westfield Mid Cap Growth Fund Columbia Funds Variable Series Trust II | 34,160 | 7.8M $ | 3.20 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 33,832 | 7.9M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Mid Cap Strategic Growth Fund VALIC Co I | 33,665 | 7.9M $ | 0.72 % | as of Feb 28, 2026 ↗ |
| LVIP Blended Mid Cap Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 33,469 | 7.7M $ | 1.14 % | as of Mar 31, 2026 ↗ |
| Schwab Select Large Cap Growth Fund LAUDUS TRUST | 32,318 | 7.4M $ | 0.37 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 32,159 | 7.5M $ | 1.03 % | as of Feb 28, 2026 ↗ |
| EQ/Janus Enterprise Portfolio EQ Advisors Trust | 31,826 | 7.3M $ | 0.54 % | as of Mar 31, 2026 ↗ |
| MFS Mid Cap Growth Series MFS VARIABLE INSURANCE TRUST | 31,632 | 7.2M $ | 2.27 % | as of Mar 31, 2026 ↗ |
| LVIP American Century Ultra(R) Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 31,076 | 7.1M $ | 0.62 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 29,377 | 6.7M $ | 0.95 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 29,200 | 6.7M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Invesco Small Cap Growth Portfolio Brighthouse Funds Trust I | 29,101 | 6.7M $ | 0.85 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 27,378 | 6.4M $ | 0.71 % | as of Feb 28, 2026 ↗ |
| Nomura VIP Asset Strategy Series Ivy Variable Insurance Portfolios | 25,419 | 5.8M $ | 1.05 % | as of Mar 31, 2026 ↗ |
| NVIT Allspring Discovery Fund Nationwide Variable Insurance Trust | 25,264 | 5.8M $ | 1.46 % | as of Mar 31, 2026 ↗ |
| Artisan Global Discovery Fund Artisan Partners Funds Inc. | 24,755 | 5.7M $ | 5.19 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 24,400 | 5.7M $ | 0.38 % | as of Feb 28, 2026 ↗ |
| Lord Abbett Growth Opportunities Fund LORD ABBETT RESEARCH FUND INC | 23,568 | 5.5M $ | 0.80 % | as of Feb 28, 2026 ↗ |
| Optimum Large Cap Growth Fund Optimum Fund Trust | 22,650 | 5.2M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 22,095 | 5.1M $ | 0.27 % | as of Mar 31, 2026 ↗ |
| Transamerica Janus Mid-Cap Growth VP TRANSAMERICA SERIES TRUST | 20,477 | 4.7M $ | 0.56 % | as of Mar 31, 2026 ↗ |
| Capital Appreciation Value Trust John Hancock Variable Insurance Trust | 19,928 | 4.6M $ | 0.98 % | as of Mar 31, 2026 ↗ |
| Allspring VT Small Cap Growth Fund Allspring VARIABLE TRUST | 19,462 | 4.5M $ | 1.68 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Midcap Value Fund BNY Mellon Advantage Funds, Inc. | 17,711 | 4.1M $ | 1.06 % | as of Feb 28, 2026 ↗ |
| Columbia Variable Portfolio - Select Mid Cap Growth Fund Columbia Funds Variable Series Trust II | 16,601 | 3.8M $ | 0.85 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 16,436 | 3.8M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Nomura VIP Mid Cap Growth Series Ivy Variable Insurance Portfolios | 16,210 | 3.7M $ | 1.10 % | as of Mar 31, 2026 ↗ |
| VIP Growth Opportunities Portfolio Variable Insurance Products Fund III | 16,125 | 3.7M $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 15,467 | 33.7M SEK | 0.12 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 14,430 | 3.3M $ | 1.45 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 14,287 | 3.3M $ | 0.04 % | as of Feb 28, 2026 ↗ |
| Small Cap Core Portfolio Bernstein Fund Inc | 14,177 | 3.2M $ | 0.45 % | as of Mar 31, 2026 ↗ |
| First Trust Innovation Leaders ETF First Trust Exchange-Traded Fund VIII | 13,998 | 3.3M $ | 1.48 % | as of Feb 28, 2026 ↗ |
| Nomura VIP Global Growth Series Ivy Variable Insurance Portfolios | 11,913 | 2.7M $ | 1.81 % | as of Mar 31, 2026 ↗ |
| MML Mid Cap Growth Fund MML SERIES INVESTMENT FUND | 11,879 | 2.7M $ | 0.77 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 11,767 | 2.7M $ | 0.17 % | as of Mar 31, 2026 ↗ |
| Loomis Sayles Small/Mid Cap Growth Fund LOOMIS SAYLES FUNDS II | 11,287 | 2.6M $ | 1.14 % | as of Mar 31, 2026 ↗ |
| Sit Mid Cap Growth Fund SIT MID CAP GROWTH FUND INC | 10,800 | 2.5M $ | 1.19 % | as of Mar 31, 2026 ↗ |
| International Small Company Fund Principal Funds, Inc | 10,780 | 2.5M $ | 0.55 % | as of Feb 28, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 10,746 | 2.5M $ | 0.23 % | as of Mar 31, 2026 ↗ |
| Optimum Small-Mid Cap Growth Fund Optimum Fund Trust | 10,193 | 2.3M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 10,163 | 2.3M $ | 1.46 % | as of Mar 31, 2026 ↗ |
| Franklin Focused Growth ETF Franklin Templeton ETF Trust | 9,854 | 2.3M $ | 1.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 9,489 | 2.2M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Putnam VT Global Health Care Fund Putnam Variable Trust | 9,264 | 2.1M $ | 1.50 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Spyglass Growth Fund Manager Directed Portfolios | 5.90 % | as of Mar 31, 2026 ↗ |
| Artisan Small Cap Fund Artisan Partners Funds Inc. | 5.87 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 5.48 % | as of Mar 31, 2026 ↗ |
| Artisan Mid Cap Fund Artisan Partners Funds Inc. | 5.25 % | as of Mar 31, 2026 ↗ |
| Artisan Global Discovery Fund Artisan Partners Funds Inc. | 5.19 % | as of Mar 31, 2026 ↗ |
| CTIVP - Westfield Select Large Cap Growth Fund Columbia Funds Variable Series Trust II | 5.18 % | as of Mar 31, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 4.24 % | as of Mar 31, 2026 ↗ |
| EVOLUTIONARY TREE INNOVATORS FUND Ultimus Managers Trust | 3.39 % | as of Feb 28, 2026 ↗ |
| CTIVP - Westfield Mid Cap Growth Fund Columbia Funds Variable Series Trust II | 3.20 % | as of Mar 31, 2026 ↗ |
| American Century Focused Dynamic Growth ETF American Century ETF Trust | 3.10 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 176 | -57 | 14,185,164 | -31.9 % |
| 2026Q1 | 233 | -4 | 20,834,535 | -4.5 % |
| 2025Q4 | 237 | +8 | 21,811,138 | +2.8 % |
| 2025Q3 | 229 | +8 | 21,210,869 | +3.0 % |
| 2025Q2 | 221 | +4 | 20,595,618 | +1.1 % |
| 2025Q1 | 217 | -9 | 20,371,716 | +0.4 % |
| 2024Q4 | 226 | +1 | 20,284,241 | -3.4 % |
| 2024Q3 | 225 | +3 | 20,997,602 | -6.3 % |
| 2024Q2 | 222 | +12 | 22,407,066 | +8.6 % |
| 2024Q1 | 210 | -4 | 20,624,306 | -12.7 % |
| 2023Q4 | 214 | 23,636,671 |
Institutional managers
264 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10,281,496 | 2.4B $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 5,062,500 | 1.2B $ | as of Mar 31, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,813,440 | 1.1B $ | as of Mar 31, 2026 |
| FMR LLC | 3,876,601 | 886.7M $ | as of Mar 31, 2026 |
| Artisan Partners Limited Partnership | 3,230,188 | 738.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,051,948 | 469.3M $ | as of Mar 31, 2026 |
| Capital International Investors | 1,958,843 | 448M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,860,669 | 425.6M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,757,633 | 402M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,531,421 | 350.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,397,119 | 319.6M $ | as of Mar 31, 2026 |
| Capital World Investors | 900,517 | 206M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 896,397 | 205M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 661,054 | 151.2M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 651,712 | 149.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 606,348 | 138.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 566,192 | 129.5M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 556,427 | 127.3M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 539,434 | 117.8M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 476,466 | 109M $ | as of Mar 31, 2026 |
| FIL Ltd | 447,421 | 102.3M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 375,000 | 85.8M $ | as of Mar 31, 2026 |
| Spyglass Capital Management LLC | 367,972 | 84.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 362,109 | 82.8M $ | as of Mar 31, 2026 |
| SEI INVESTMENTS CO | 351,146 | 80.3M $ | as of Mar 31, 2026 |
Declared shareholders of Ascendis Pharma A/S
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.50 % | 6,506,219 | as of Apr 30, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP PLC | 6.00 % | 3,719,452 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital International Investors | 3.20 % | 2,013,285 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Ascendis Pharma A/S
16 funds declare 16 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Funds holding Ascendis Pharma A/S". https://titelia.com/en/stocks/ascendis-pharma-a-s-US04351P1012